His investors only eventually made money after Shkreli paid them in stock and cash from Retrophin.
Prosecutors, on the other hand, have argued that Shkreli should not get any credit for what they described as stealing from Retrophin to pay off the investors.
His investors only eventually made money after Shkreli paid them in stock and cash from Retrophin.
Prosecutors, on the other hand, have argued that Shkreli should not get any credit for what they described as stealing from Retrophin to pay off the investors.
source: https://www.cnbc.com/2018/03/09/pharma-bro-shkreli-to-be-sen...